Rezultati - Busque, Stephan
- Showing 1 - 20 results of 21
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
SARS-CoV-2 Neutralizing Monoclonal Antibodies for the Treatment of COVID-19 in Kidney Transplant Recipients od Wang, Aileen X., Busque, Stephan, Kuo, Jamie, Singh, Upinder, Röeltgen, Katharina, Pinsky, Benjamin A., Chertow, Glenn M., Scandling, John D., Lenihan, Colin R.
Izdano 2021Text -
15
Tolerance and Withdrawal of Immunosuppressive Drugs in Patients Given Kidney and Hematopoietic Cell Transplants od Scandling, John D., Busque, Stephan, Dejbakhsh-Jones, Sussan, Benike, Claudia, Sarwal, Minnie, Millan, Maria T., Shizuru, Judith A., Lowsky, Robert, Engleman, Edgar G., Strober., Samuel
Izdano 2012Text -
16
Trends in Cost Attributable to Kidney Transplantation Evaluation and Waiting List Management in the United States, 2012-2017 od Cheng, Xingxing S., Han, Jialin, Braggs-Gresham, Jennifer L., Held, Philip J., Busque, Stephan, Roberts, John P., Tan, Jane C., Scandling, John D., Chertow, Glenn M., Dor, Avi
Izdano 2022Text -
17
Efficacy and Safety of a Tofacitinib-based Immunosuppressive Regimen After Kidney Transplantation: Results From a Long-term Extension Trial od Busque, Stephan, Vincenti, Flavio G., Tedesco Silva, Helio, O’Connell, Philip J., Yoshida, Atsushi, Friedewald, John J., Steinberg, Steven M., Budde, Klemens, Broeders, Emine N., Kim, Yon Su, Hahn, Carolyn M., Li, Huihua, Chan, Gary
Izdano 2018Text -
18
Cellular and humoral immune response to SARS-CoV-2 vaccination and booster dose in immunosuppressed patients: An observational cohort study od Yang, Lu M., Costales, Cristina, Ramanathan, Muthukumar, Bulterys, Philip L., Murugesan, Kanagavel, Schroers-Martin, Joseph, Alizadeh, Ash A., Boyd, Scott D., Brown, Janice M., Nadeau, Kari C., Nadimpalli, Sruti S., Wang, Aileen X., Busque, Stephan, Pinsky, Benjamin A., Banaei, Niaz
Izdano 2022Text -
19
Mixed chimerism and acceptance of kidney transplants after immunosuppressive drug withdrawal od Busque, Stephan, Scandling, John D., Lowsky, Robert, Shizuru, Judith, Jensen, Kent, Waters, Jeffrey, Wu, Hsin-Hsu, Sheehan, Kevin, Shori, Asha, Choi, Okmi, Pham, Thomas, Fernandez Vina, Marcelo A., Hoppe, Richard, Tamaresis, John, Lavori, Philip, Engleman, Edgar G., Meyer, Everett, Strober, Samuel
Izdano 2020Text -
20
Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti‐CD20 monoclonal antibody for the desensitization of candidates for renal transplant od Redfield, Robert R., Jordan, Stanley C., Busque, Stephan, Vincenti, Flavio, Woodle, E. Steve, Desai, Niraj, Reed, Elaine F., Tremblay, Simon, Zachary, Andrea A., Vo, Ashley A., Formica, Richard, Schindler, Thomas, Tran, Ha, Looney, Caroline, Jamois, Candice, Green, Cherie, Morimoto, Alyssa, Rajwanshi, Richa, Schroeder, Aaron, Cascino, Matthew D., Brunetta, Paul, Borie, Dominic
Izdano 2019Text